NASDAQ · Medical - Diagnostics & Research

Prenetics Global Limited - Class A Ordinary Share (PRE) Stock

$22.00 -2.09% NASDAQ: PRE Healthcare

Valuation

MetricValue
Price$22.00
Market Cap$374.01M
P/E Ratio-4.85
P/B Ratio3.74
P/S Ratio2.41
EPS (TTM)$-2.68
52-Week High$27.24
52-Week Low$11.37
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-49.17%
ROA-44.00%
ROCE-42.85%
Gross Margin-42.39%
Operating Margin-41.30%
Net Margin-47.43%
Debt/Equity0.01
Current Ratio2.96

Annual Financials (USD)

Metric20212022202320242025
Revenue$13.0M$13.0M$22.0M$31.0M$92.0M
Operating Profit$-57.0M$-66.0M$-52.0M$-48.0M$-38.0M
Net Profit$-174.0M$-190.0M$-63.0M$-46.0M$-38.0M
EPS$-47.04$-37.57$-5.58$-3.64$-2.68
Op Margin-452.1%-501.5%-238.7%-157.2%-41.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$149.0M$312.0M$254.0M$214.0M$204.0M
Total Liabilities$549.0M$69.0M$44.0M$42.0M$29.0M
Cash$35.0M$147.0M$46.0M$52.0M$32.0M
Borrowings$492.0M$7.0M$2.0M$6.0M$2.0M

Latest News

PRE Continues to Exceed Expectations and Receive Preferential Financing Zacks Small Cap Research · Jul 15, 2026 Sector Update: Healthcare Stocks Fall Late Afternoon MT Newswires · Jul 14, 2026 Sector Update: Healthcare MT Newswires · Jul 14, 2026 Market Chatter: IM8, Co-Founded by Prenetics and David Beckham, Gets General Catalyst Financing MT Newswires · Jul 14, 2026 Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF) GlobeNewswire · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$13.0M$15.0M$-14.0M$-29.0M$-22.0M
Investing Cash Flow$-33.0M$-52.0M$-84.0M$37.0M$-36.0M
Financing Cash Flow$5.0M$145.0M$-1.0M$-1.0M$-3.0M
Net Cash Flow$21.0M$111.0M$-101.0M$7.0M$-20.0M
Free Cash Flow$2.0M$8.0M$-15.0M$-30.0M$-22.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.42
EV / EBITDA-4.55
FCF Yield-9.96%
Quick Ratio3.66
Interest Coverage-411.31
Return 1Y125.03%
Return 3Y59.05%
Return 5Y-83.21%

Ownership

Insiders Held14.17%
Institutions Held12.84%
Institutions Float Held14.95%
Institutional HolderSharesReport Date
Prudential PLC427,9632026-03-31
Aspex Management (HK) Ltd346,1502026-03-31
Tenzing Global Management, Llc200,0002026-03-31
Goldman Sachs Group Inc193,5832026-03-31
Millennium Management Llc192,6002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARMPArmata Pharmaceuticals, Inc. $3.82 -1.17% -0.72 $140.05M 0.00%
ATLN $0.90 +0.00% -1.31 $73.17M 0.00%
CDXSCodexis, Inc. $1.36 -3.55% -4.05 $146.28M 0.00%
IMDXInsight Molecular Diagnostics Inc. $3.30 +0.61% -2.12 $106.56M 0.00%
MXCTMaxCyte, Inc. $0.99 -2.50% -3.20 $106.53M 0.00%

About Prenetics Global Limited - Class A Ordinary Share

Prenetics Global Limited - Class A Ordinary Share is led by CEO Sheng Wu Yeung, publicly traded since 2021.

Prenetics Global Limited - Class A Ordinary Share (PRE) stock trades at $22.00 with a market capitalization of $374.01M. The stock is valued at a price-to-earnings (P/E) ratio of -4.85, price-to-book of 3.74, price-to-sales of 2.41. Over the past 52 weeks the stock has ranged between $11.37 and $27.24, and currently trades 19.2% below its 52-week high.

On profitability, Prenetics Global Limited - Class A Ordinary Share generates a return on equity (ROE) of -49.17%, return on capital employed of -42.85%, an operating margin of -41.30%, a net profit margin of -47.43%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1171.00 +0.12% JNJ Johnson & Johnson $259.44 +1.15% ABBV AbbVie Inc. $275.16 +1.01% MRK Merck & Company, Inc. Common Stock (new) $144.72 +1.64% UNH UnitedHealth Group Incorporated Common Stock (DE) $374.26 +0.89% NVS Novartis AG $143.67 +0.39% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $654.06 +0.32% AMGN Amgen Inc. $411.01 +0.88% GILD Gilead Sciences, Inc. $148.75 +1.12% ABT Abbott Laboratories $99.36 +0.88% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides